Finger Movement Training for Stroke
Trial Summary
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Research shows that robotic hand movement therapy, like HEXORR II, can improve hand function and reduce muscle tightness in stroke patients. Additionally, home-based therapy with devices like HandSOME II has been shown to improve hand movement and real-world use of the impaired limb, with benefits lasting for months.
12345Research on various hand exoskeleton devices, including HandSOME II, HEXORR II, and RobHand, shows they are generally safe for use in humans, with no significant adverse events reported. Studies on healthy individuals and stroke patients found these devices comfortable and reliable, with no serious side effects.
23678The Actuated Hand Exoskeleton is unique because it uses soft, pneumatically controlled actuators to help stroke survivors extend their fingers, allowing for more natural hand movements. Unlike other devices, it is lightweight and conforms to the hand's shape, providing independent assistance to each finger while allowing full arm movement, which is crucial for effective rehabilitation.
59101112Eligibility Criteria
This trial is for stroke survivors who are 2-6 months post-stroke, can consent, see shapes on a screen, and have moderate to mild hand impairment without severe pain or joint issues that would prevent movement.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo a 5-week intervention involving 15 training sessions to improve hand function using targeted electrical stimulation and a hand exoskeleton
Follow-up
Participants are monitored for safety and effectiveness after treatment, with evaluations occurring at the midpoint, after completion, and one month later